BPaL/M is a six-month all-oral regimen recommended by the World Health Organization (WHO) to treat most forms of ...

Global access to tuberculosis (TB) medicine pretomanid received a shot in the arm, as its price saw a 25% drop, thanks to a ...

BPaL/M treatment is an oral regimen that consists of the TB drugs bedaquiline, pretomanid and linezolid, with or without moxifloxacin, and is recommended by the WHO. Drug-resistant tuberculosis is ...

The treatment, called PP353, combines three widely used substances: linezolid, an antibiotic; iohexol, a contrast agent; and a thermosensitive gel that helps deliver the drug directly to the site ...

TB Alliance's third licensed manufacturer makes pretomanid available through the Global Drug Facility, further improving ...

The third largest drug class — the fluoroquinolones ... Johnson & Johnson), moxifloxacin (Avelox; Bayer/Merck) and linezolid (Zyvox; Pfizer), which are expected to lose patent protection ...

By Sharon AtienoThe price of pretomanid, the newest tuberculosis (TB) medicine, dropped to less than a dollar per day in April.The drug is now available through the Global Drug Facility (GDF) for ...

After approval of the study protocol by the ethics committee of the Medical Faculty of the University of Heidelberg, we evaluated parenteral drug treatment in patients admitted to a 12-bed ICU in ...

In Kenyan children who received azithromycin after hospital discharge, the presence of a macrolide-resistance gene was tied ...